Table 2.
Clinical and metabolic features of PCOS-IR patients and control subjects
| Characteristics | PCOS-IR (n=80) | Control (n=50) | P |
|---|---|---|---|
| Age (y) | 27.54±4.74 | 28.14±4.47 | 0.47 |
| FSH (IU/L) | 5.85±2.08 | 6.59±3.07 | 0.10 |
| LH (IU/L) | 11.37±7.47 | 6.9±8.7 | <0.05 |
| LH/FSH | 1.97±1.08 | 1.00±0.71 | <0.05 |
| PRL (μg/L) | 19.94±65.85 | 15.29±14.15 | 0.62 |
| E2 (pmol/L) | 245.45±183.31 | 278.55±193.23 | 0.33 |
| PRGE (nmol/L) | 2.89±1.65 | 2.17±0.87 | 0.35 |
| TT (nmol/L) | 3.02±0.6 | 1.48±0.45 | <0.001 |
| Insulin (0 h) (μU/mL) | 16.79±8.4 | 6.57±1.45 | <0.001 |
| Glucose (0 h) (mmol/L) | 5.4±1.53 | 5.23±0.53 | 0.45 |
| HOMA-IR | 4±2.29 | 1.53±0.36 | <0.001 |